This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

PROF. V. GILSANZ; A. BARRERA, M.D.; A. ANAYA, M.D.

AMA Arch Intern Med. 1960;105(5):758-761.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The most significant biochemical alterations in Wilson's disease are manifested in the metabolism of copper and aminoaciduria. The excessive copper eliminated in the urine, the notable reduction in serum ceruloplasmin, etc., have recently been studied by means of isotopes, and there is still no clear and certain concept as to pathogenesis. Much less verified is the hypothesis which ascribes the initial defect to a deficiency in ceruloplasmin, an inborn metabolic error which gives rise to a defect in the synthesis of this -globulin—thus promoting a greater absorption of copper by the intestines and subsequent increased excretion of copper in the urine.

Cartwright has not found any correlation between the blood ceruloplasmin levels and the clinical course in Wilson's disease in 39 patients. On the other hand some authors, such as Uzman, suggest that the primary factor in Wilson's disease is the aminoaciduria. In favor of this hypothesis is the fact . . . [Full Text PDF of this Article]

Author Affiliations
Madrid, Spain

Departments of Internal Medicine, University of Madrid (Prof. Dr. V. Gilsanz).

Footnotes
Submitted for publication July 3, 1959.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?